Yale Spinout Celldex Therapeutics Announces Positive Topline Results from Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria
Cover Story: Cross-disciplinary project led by Dr. Ranjit Bindra with The Saltzman Research Group at Yale aims to tackle the toughest oncology problems
Clinician and professor Amber Childs is the cofounder of Yale’s innovative GROW (Getting Racism Out of Work) Initiative
Prepared (co-founded by Michael Chime YC ’21, Dylan Gleicher YC ’21, and Neal Soni YC ’22) closes a $16 Million round